Viewing Study NCT03085368


Ignite Creation Date: 2025-12-24 @ 5:47 PM
Ignite Modification Date: 2025-12-24 @ 5:47 PM
Study NCT ID: NCT03085368
Status: UNKNOWN
Last Update Posted: 2017-07-28
First Post: 2017-03-19
Is Possible Gene Therapy: False
Has Adverse Events: False

Brief Title: A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin
Sponsor: Peking Union Medical College Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: lapatinib
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View